Early reduction in standardized uptake value after one cycle of neoadjuvant chemotherapy measured by sequential FDG PET/CT is an independent predictor of pathological response of primary breast cancer.
Shigeto
S
Ueda
Hitoshi
H
Tsuda
Toshiaki
T
Saeki
Akihiko
A
Osaki
Takashi
T
Shigekawa
Jiro
J
Ishida
Katsumi
K
Tamura
Yoshiyuki
Y
Abe
Jiro
J
Omata
Tomoyuki
T
Moriya
Kazuhiko
K
Fukatsu
Junji
J
Yamamoto
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18